SV Health Investors

Funding rounds backed by SV Health Investors.

Export CSV
Funding disclosed in full
$463M
Median round
$57.5M
Rounds in calculation
4
4 rounds
LatestLargest
Funding rounds with company descriptions, amounts, stages and announcement dates
CompanyRoundMarketInvestorsAnnouncedDetails
AdvanCell

Develops lead-212 targeted alpha therapies to treat cancer

$315MSeries DBiotechAustralia
19 participantsAbingworthAlly Bridge GroupAlpha WaveBain Capital Life SciencesBrandon CapitalCatalio Capital ManagementEli Lilly and CompanyEventide Asset ManagementFidelity Management & Research CompanyMorningsidePiper HeartlandProto AxiomSanofi VenturesSV Health InvestorsSymBiosisTenmileTime BioVenturesT. Rowe Price AssociatesVelosity Capital
Draig Therapeutics

Developing transformative, best-in-class neuropsychiatric therapies

$65MSeries BBiotechUnited Kingdom
12 participantsAccess BiotechnologyBritish Business BankCanaan PartnersDeep Track CapitalICGJanus Henderson InvestorsJefferson Life SciencesMarshall WaceSanofi VenturesSchroders CapitalSR OneSV Health Investors
TRex Bio

Develops precision immunoregulatory medicines based on tissue Treg biology

$50MUndisclosedBiotechUnited States
11 participantsAffinity Asset AdvisorsAlexandria Venture InvestmentsAvego BioScience CapitalBalyasny Asset ManagementDelos CapitalEli Lilly and CompanyJanus Henderson InvestorsJohnson & Johnson Innovation – JJDCPfizer VenturesPolaris PartnersSV Health Investors
PayMedix

Provides healthcare financing and payments solutions

$33MUndisclosedHealthtechUnited States
4 participantsEscalate Capital PartnersHLM Investment PartnersRVM EnterprisesSV Health Investors